Impact of milk-phospholipids compared to triacylglycerols on risk factors related to metabolic syndrome

Not Applicable

• Conditions: E88.9; Metabolic disorder, unspecified

• Registration Number: DRKS00000383
• Lead Sponsor: Max Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebnsmittel

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04-13
• Study Completion: 2010-07-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 62

Inclusion Criteria

Male gender, overweight
Between 50 and 75 years of age
Non-smoker
Subjects who gave written consent to participate in this study

Exclusion Criteria

Subjects with fasting glucose above 120 mg/dl
Subjects suffering from a disease regarding the resorption of nutrients, digestive function, metabolism, or excretion
Subjects with a known milk protein allergy
Subjects taking nutritional supplements during the trial period which can influence study parameters
Subjects taking medications which can influence study parameters
Subjects that underwent surgery of the gastrointestinal tract or a corticoid treatment within the past three months
Subjects with an above average consumption of milk and milk products
Subjects experiencing unjustifiable adverse events
Subjects experiencing acute gastrointestinal disease during the trial period
Subjects who do not act compliantly
Subjects who withdraw their consent to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum total- and HDL cholesterol ratio at the end of intervention (after 8 weeks)

Secondary Outcome Measures

Name	Time	Method
Risk factors for the metabolic syndrome at the end of intervention (after 8 weeks): waist circumference, fasting blood triacylglycerol and glucose, blood pressure